CommentaryINSIDER VIEWS

What Is the Greatest Regulatory Challenge in the Translation of Biomaterials to the Clinic?

Science Translational Medicine  14 Nov 2012:
Vol. 4, Issue 160, pp. 160cm14
DOI: 10.1126/scitranslmed.3004915

You are currently viewing the abstract.

View Full Text

Log in


Abstract

Leaders in the field comment on what they perceive to be the greatest barriers to biomaterial translation.

View Full Text